[A case of unresectable hilar bile duct cancer responding to chemo-radiotherapy by gemcitabine]

Gan To Kagaku Ryoho. 2009 Oct;36(10):1753-5.
[Article in Japanese]

Abstract

A 66-year-old woman was admitted to our hospital because of general fatigue and icterus. PTC findings showed irregular stenosis of hilar bile duct. Abdominal CT scan showed a dilatation of the intra-hepatic bile duct and a tumor around hilar bile duct. We diagnosed it as hilar bile duct carcinoma, and although we operated it was unresectable because of the metastasis of a para-aorta lymph node and duodenal invasion. We started chemo-radiotherapy with a total dose of 45 Gy and gemcitabine. The tumor and para-aorta lymph node were remarkably decreased, and tumor marker CA 19-9 was also decreased to within the normal range. The patient had a peritoneal dissemination 10 months after the chemo-radiotherapy and survived 20 months.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Bile Duct Neoplasms / diagnostic imaging
  • Bile Duct Neoplasms / drug therapy*
  • Bile Duct Neoplasms / radiotherapy*
  • Bile Duct Neoplasms / surgery
  • Biomarkers, Tumor / blood
  • Combined Modality Therapy
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Duodenal Neoplasms / diagnostic imaging
  • Duodenal Neoplasms / drug therapy
  • Duodenal Neoplasms / secondary
  • Fatal Outcome
  • Female
  • Gemcitabine
  • Humans
  • Lymphatic Metastasis
  • Neoplasm Invasiveness
  • Radiography

Substances

  • Antimetabolites, Antineoplastic
  • Biomarkers, Tumor
  • Deoxycytidine
  • Gemcitabine